πŸ‡ΊπŸ‡Έ FDA
Patent

US 11008372

Targeting proteins for degradation

granted A61KA61K38/00A61K38/1709

Quick answer

US patent 11008372 (Targeting proteins for degradation) held by The Board of Regents of the University of Texas System expires Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue May 18 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K38/00, A61K38/1709, A61P, A61P35/00